ARBUCKLE STUART A (EVP\Chief Commercial Officer) received a stock award from VERTEX PHARMACEUTICALS INC / MA
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 2/6/2025ACC: 0000875320-25-000009
Officer· EVP\Chief Commercial Officer
Since Jun 2018
+23.07K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
23.07K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+14.62K
Price / share
—
Trade value
—
% of position
29.4%
2/4/2025
49.69K→64.31K
Common Stock
Direct
Shares
+8.45K
Price / share
—
Trade value
—
% of position
13.1%
2/4/2025
64.31K→72.76K
Total
Net shares
+23.07K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/4/2025 | A · Award | +14.62K | — | — | 29.4% | 49.69K | 64.31K |
| Common Stock Direct | 2/4/2025 | A · Award | +8.45K | — | — | 13.1% | 64.31K | 72.76K |
| Total | +23.07K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned140.00
Total
140.00 indirect140.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 140.00 | Indirect |
| Total | 140.00 | 140.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported